PATENT CLAIM ANALYSIS

Application Number: 16060659
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "552000"]

Abstract:
The invention provides a pro-resolving mediator for use in the reduction of reactogenicity induced by administration of a vaccine or immunogenic composition comprising at least an antigen, and vaccines or immunogenic compositions comprising such a pro-resolving mediator.

Claim (Index 11):
The method of  claim 1 , wherein the pro-resolving mediator is administered 5, 10, 20, 30, 45 minutes or more, or 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 hours or more before administration of the vaccine or immunogenic composition, in particular between 30 minutes and 3 hours, in particular about 1 hour.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 94.0
- Lexical Diversity: 1.25806
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12103136', '12596202', '13020045', '15446508', '15354233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7294531859494199
- 35 USC 102 Novelty (BERT): 0.520560389167563
- Combined Prediction Score: 0.7085639062712341
- Mean Citation Score: 223.322114
- Max Citation Score: 239.91882
- Similarity Product: 140.4630027848697

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test